Whilst price cut cards may help reduce the burden of higher drug expenses during the temporary, they do not address the systemic troubles driving up prescription charges within the U.S. Broader plan alterations could tackle the basis results in of growing drug costs, for example not enough transparency in pricing and the position of intermediaries